Accelerated apoptotic death and <i>in vivo</i> turnover of erythrocytes in mice lacking functional mitogen- and stress-activated kinase MSK1/2 by Lang, Elisabeth et al.
                                                              
University of Dundee
Accelerated apoptotic death and in vivo turnover of erythrocytes in mice lacking
functional mitogen- and stress-activated kinase MSK1/2
Lang, Elisabeth; Bissinger, Rosi; Fajol, Abul; Salker, Madhuri S.; Singh, Yogesh; Zelenak,
Christine; Ghashghaeinia, Mehrdad; Gu, Shuchen; Jilani, Kashif; Lupescu, Adrian; Reyskens,
Kathleen M. S. E.; Ackermann, Teresa F.; Föller, Michael; Schleicher, Erwin; Sheffield,
William P.; Arthur, John; Lang, Florian; Qadri, Syed M.
Published in:
Scientific Reports
DOI:
10.1038/srep17316
Publication date:
2015
Document Version
Publisher's PDF, also known as Version of record
Link to publication in Discovery Research Portal
Citation for published version (APA):
Lang, E., Bissinger, R., Fajol, A., Salker, M. S., Singh, Y., Zelenak, C., ... Qadri, S. M. (2015). Accelerated
apoptotic death and in vivo turnover of erythrocytes in mice lacking functional mitogen- and stress-activated
kinase MSK1/2. Scientific Reports, 5, 1-10. [17316]. DOI: 10.1038/srep17316
General rights
Copyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other
copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with
these rights.
 • Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research.
 • You may not further distribute the material or use it for any profit-making activity or commercial gain.
 • You may freely distribute the URL identifying the publication in the public portal.
1Scientific RepoRts | 5:17316 | DOI: 10.1038/srep17316
www.nature.com/scientificreports
Accelerated apoptotic death and 
in vivo turnover of erythrocytes in 
mice lacking functional mitogen- 
and stress-activated kinase 
MSK1/2
Elisabeth Lang1,2, Rosi Bissinger1, Abul Fajol1, Madhuri S. Salker1, Yogesh Singh1, 
Christine Zelenak3, Mehrdad Ghashghaeinia1, Shuchen Gu1,4, Kashif Jilani1,5, 
Adrian Lupescu1, Kathleen M. S. E. Reyskens6,7, Teresa F. Ackermann1, Michael Föller1,11, 
Erwin Schleicher8, William P. Sheffield9,10, J. Simon C. Arthur6,7, Florian Lang1 & 
Syed M. Qadri1,9,10
The mitogen- and stress-activated kinase MSK1/2 plays a decisive role in apoptosis. In analogy 
to apoptosis of nucleated cells, suicidal erythrocyte death called eryptosis is characterized by cell 
shrinkage and cell membrane scrambling leading to phosphatidylserine (PS) externalization. Here, 
we explored whether MSK1/2 participates in the regulation of eryptosis. To this end, erythrocytes 
were isolated from mice lacking functional MSK1/2 (msk−/−) and corresponding wild-type mice 
(msk+/+). Blood count, hematocrit, hemoglobin concentration and mean erythrocyte volume were 
similar in both msk−/− and msk+/+ mice, but reticulocyte count was significantly increased in msk−/− 
mice. Cell membrane PS exposure was similar in untreated msk−/− and msk+/+ erythrocytes, but was 
enhanced by pathophysiological cell stressors ex vivo such as hyperosmotic shock or energy depletion 
to significantly higher levels in msk−/− erythrocytes than in msk+/+ erythrocytes. Cell shrinkage 
following hyperosmotic shock and energy depletion, as well as hemolysis following decrease of 
extracellular osmolarity was more pronounced in msk−/− erythrocytes. The in vivo clearance of 
autologously-infused CFSE-labeled erythrocytes from circulating blood was faster in msk−/− mice. The 
spleens from msk−/− mice contained a significantly greater number of PS-exposing erythrocytes than 
spleens from msk+/+ mice. The present observations point to accelerated eryptosis and subsequent 
clearance of erythrocytes leading to enhanced erythrocyte turnover in MSK1/2-deficient mice.
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The closely related mitogen- and stress-activated kinases MSK1 and MSK2 are involved in signal trans-
duction that governs survival and apoptosis of nucleated cells1–7. Stimulators of MSK1 include the 
Ras-mitogen-activated protein kinase (MAPK)/p38 MAPK signal transduction pathway1,8–10. MSK1 par-
ticipates in a wide array of cellular functions, including regulation of immediate-early gene expression9,11, 
an effect attributed to its ability to phosphorylate histone H1 and H3 and thus fostering the modification 
of chromatin structure3,6,9,12. Moreover, MSK1 contributes to the regulation of NF-κ B activation2,13, of 
cAMP-response element11,14,15, of caspase activity16 and of Bad phosphorylation17. Furthermore, MSK1/2 
deficiency enhances the formation of PGE218.
Similar to nucleated cells, erythrocytes may undergo suicidal death or eryptosis, which is charac-
terized by cell shrinkage and cell membrane scrambling19. Triggers of eryptosis include activation of 
Ca2+-permeable cation channels20–26, which are activated by PGE227. The activation of the channels leads 
to Ca2+ entry, activation of Ca2+-sensitive K+ channels, exit of KCl with osmotically obliged water and, 
thus, to cell shrinkage28. Cytosolic Ca2+ further stimulates scrambling of the erythrocyte membrane with 
exposure of phosphatidylserine at the cell surface26,29–32. The Ca2+ sensitivity of cell membrane scram-
bling is increased by ceramide33. Phosphatidylserine exposing erythrocytes are rapidly phagocytosed 
and thus cleared from circulating blood34–37. Accordingly, accelerated eryptosis enhances the turnover of 
erythrocytes, which may lead to anemia, if the accelerated loss of erythrocytes is not compensated by a 
similar increase of erythrocyte formation, which is evident from reticulocytosis19.
In the present study, we explored whether MSK1/2 influences the survival of erythrocytes in response 
to pathophysiological cell stressors such as hyperosmotic shock and energy depletion. To this end, the 
eryptotic phenotype was characterized in mice lacking functional MSK1/2 (msk−/−) and their corre-
sponding wild type mice (msk+/+).
Results
Absence of overt anemia but increased reticulocytosis in msk−/− mice. The present study 
addressed the impact of MSK1/2 on eryptosis in mice. To this end, experiments were performed in mice 
lacking functional MSK1/2 (msk−/−) and corresponding wild type mice (msk+/+). As a first approach, 
a blood count was performed. As shown in Table  1, erythrocyte count (RBC), hemoglobin concentra-
tion (HGB), hematocrit (HCT), mean corpuscular volume (MCV), and mean corpuscular hemoglobin 
concentration (MCHC) were not significantly different between msk−/− than in msk+/+ mice. Mean cor-
puscular hemoglobin (MCH) was, however, slightly but significantly increased in msk−/− as compared 
to msk+/+ mice (Table  1). Reticulocyte count was significantly higher in msk−/− than in msk+/+ mice, 
pointing to enhanced erythrocyte formation in msk−/− mice (Table 1).
Expression of MSK1 and MSK2 in human and murine erythrocytes. Immunoblotting was 
employed to test whether MSK1 and/or MSK2 are expressed in erythrocytes. To this end, erythrocytes 
from humans or from mice were isolated and purified. Equal amounts of protein lysates were made 
and immunoblotting was performed. GAPDH served as a loading control. Expression of MSK1 and 
MSK2 was determined in lysates from murine whole blood and from purified murine erythrocytes. As 
illustrated in Fig. 1, the incubation with MSK1 and MSK2 specific antibodies both yielded a band of 90 
(MSK1) and 86 (MSK2) kDa in murine and human erythrocytes, respectively.
Increased susceptibility of msk−/− erythrocytes to osmosensitive eryptosis and hemolysis. 
Further experiments then addressed the susceptibility of MSK1/2-deficient erythrocytes to osmotic 
shock, a known stimulator of eryptosis, i.e. increase of phosphatidylserine exposure and decrease of 
cell volume26. Prior to osmotic shock, annexin V-binding reflecting phosphatidylserine exposure at the 
erythrocyte surface was similar in both msk−/− and msk+/+ erythrocytes (Fig.  2). Following exposure 
Parameter msk+/+ msk−/− Units
RBC 12.0 ± 0.5 11.4 ± 0.6 × 106/μ l
HGB 15.9 ± 0.6 15.7 ± 0.9 g/dl
HCT 45.8 ± 4.9 43.5 ± 5.4 %
MCV 37.8 ± 2.7 37.3 ± 3.1 fl
MCH 13.3 ± 0.1 13.8 ± 0.1* pg
MCHC 36.3 ± 2.6 38.5 ± 3.1 g/dl
RTC 3.5 ± 0.3 4.7 ± 0.3* %
Table 1.  Blood count and reticulocyte number in msk−/− and msk+/+ mice. Means ± SEM (n = 3− 7) of 
erythrocyte count (RBC), haemoglobin concentration (HGB), haematocrit (HCT), mean corpuscular volume 
(MCV), mean corpuscular haemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), 
reticulocyte count (RTC) of 9–16 week-old MSK1-deficient mice (msk−/−) and wild type mice (msk+/+).  
* significant (p < 0.05) differences between genotypes (t-test).
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Figure 1. MSK1 and MSK2 expression in murine and human erythrocytes. (A) Original Western blots of 
MSK1 (~90 kDa) and GAPDH (~37 kDa) in murine whole blood (lane 1), 1:6.4 diluted whole blood (lane 2) 
and purified erythrocyte (RBC) preparation (lane 3) and human erythrocytes (lane 4). (B) Original Western 
blots of MSK2 (~86 kDa) and GAPDH (~37 kDa) in murine whole blood (lane 1), 1:3.7 diluted whole blood 
(lane 2) and purified erythrocyte (RBC) preparation (lane 3) and human erythrocytes (lane 4).
Figure 2. Effect of hyperosmolarity on phosphatidylserine abundance at the surface of erythrocytes 
from msk−/− and msk+/+ mice. (A) Histogram overlay and (B) Means ± SEM (n = 7) of annexin V-binding 
erythrocytes in isosmotic (black line) or hyperosmotic (red line, + 550 mM sucrose) Ringer. #,###(p < 0.05; 
p < 0.001) from isosmotic, ***(p < 0.001) from msk+/+.
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of erythrocytes for 1 h to hyperosmotic Ringer (addition of 550 mM sucrose), however, the annexin 
V-binding was significantly higher in msk−/− than in msk+/+ erythrocytes (Fig. 2). To depict cell shrink-
age, forward scatter of msk−/− and msk+/+ erythrocytes was determined in flow cytometer analysis. As 
shown in Fig. 3, forward scatter was significantly reduced by hyperosmotic shock in erythrocytes from 
both msk−/− and msk+/+ mice. The effect, however, tended to be more pronounced in msk−/− eryth-
rocytes than in msk+/+ erythrocytes. Further experiments explored the resistance of erythrocytes to a 
decline of extracellular osmolarity. As illustrated in Fig. 4, the resistance of erythrocytes to decreases of 
osmolarity was significantly lower in msk−/− than in msk+/+ mice. Thus, MSK1/2 deficiency enhances the 
sensitivity of erythrocytes to both hyper- and hypoosmotic shock.
Increased vulnerability of msk−/− erythrocytes to energy-sensitive eryptosis. Additional 
experiments were performed in the presence and absence of glucose, as energy depletion is known to 
Figure 3. Effect of hyperosmolarity on forward scatter of erythrocytes from msk−/− and msk+/+ mice. 
(A) Histogram overlay and (B) Means ± SEM (n = 7) of erythrocyte FSC Geomean in isosmotic (black line) 
or hyperosmotic (red line, + 550 mM sucrose) Ringer. ###(p < 0.001) from isosmotic.
Figure 4. Osmotic resistance of erythrocytes from msk−/− and msk+/+ mice. Means ± SEM (n = 3− 4) of 
relative hemolysis as a function of extracellular osmolarity (% hyposmolar of isomotic Ringer). *,**(p < 0.05, 
p < 0.01) from msk+/+.
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foster eryptosis38. As shown in Fig. 5, annexin V-binding reflecting phosphatidylserine exposure at the 
erythrocyte surface was significantly increased by 12 h glucose depletion, an effect significantly higher in 
msk−/− than in msk+/+ erythrocytes. Furthermore, as shown in Fig. 6, forward scatter was significantly 
reduced by energy depletion in erythrocytes from both msk−/− and msk+/+ mice. This effect tended to 
be larger in msk−/− than in msk+/+ erythrocytes, an effect, however, not reaching statistical significance 
(Fig. 6).
Enhanced in vivo clearance and entrapment of eryptotic erythrocytes in the spleens of 
msk−/− mice. Eryptotic erythrocytes are rapidly cleared from circulating blood36. Thus, additional 
experiments were performed to disclose a possible effect of MSK1/2 deficiency on erythrocyte clearance. 
To determine the life span of circulating erythrocytes, blood was drawn from msk−/− and msk+/+ mice 
and erythrocytes were labelled with CFSE and injected autologously in the mice of the respective gen-
otype. As shown in Fig.  7A, within 4 and 5 days CFSE-labeled msk−/− erythrocytes disappeared from 
circulating blood of msk−/− mice more rapidly than CFSE-labeled msk+/+ erythrocytes from circulat-
ing blood of msk+/+ mice. Thus, the life span of msk−/− erythrocytes in msk−/− mice was significantly 
shorter than the life span of msk+/+ erythrocytes in msk+/+ mice. The labelled erythrocytes were mainly 
trapped in the spleen. The ratio of spleen weight to body weight was slightly but significantly larger in 
msk−/− mice as compared to msk+/+ mice (Fig. 7B). The number of fluorescent annexin V-binding and 
thus phosphatidylserine-exposing erythrocytes as visualized by fluorescence confocal microscopy was 
again higher in the spleens from msk−/− mice than in the spleens from msk+/+ mice reflecting enhanced 
trapping of eryptotic erythrocytes in msk−/− mice (Fig. 7C,D).
Discussion
According to the present observations, a lack of MSK1/2 enhances the susceptibility of erythrocytes 
to undergo suicidal erythrocyte death or eryptosis following pathophysiological cell stressors such as 
hyperosmotic shock and energy depletion. The MSK1/2-deficient (msk−/−) mice did not exhibit overt 
anemia but showed marked increase in erythrocyte turnover that contributes to a mild increase in 
splenic mass. Moreover, the erythrocytes from msk−/− mice are more sensitive than erythrocytes from 
msk+/+ mice to triggers of eryptosis, including hyperosmotic shock and energy depletion. On the other 
hand, MSK1/2 deficiency decreases the resistance against hemolysis following decrease of extracellular 
Figure 5. Effect of energy depletion on phosphatidylserine abundance at the surface of erythrocytes 
from msk−/− and msk+/+ mice. (A) Histogram overlay and (B) Means ± SEM (n = 3− 4) of annexin 
V-binding erythrocytes in glucose-containing (black line, + Glucose) or glucose-depleted (red line, 
− Glucose) Ringer. ###(p < 0.001) from + Glucose. ***(p < 0.001) from msk+/+.
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osmolarity. Apparently, MSK1/2 deficiency increases the sensitivity of erythrocytes to both cell shrinkage 
and cell swelling.
Hyperosmotic shock and energy deletion trigger eryptosis only in a subset of the erythrocyte popula-
tion, indicating that the circulating erythrocytes are not uniformly sensitive to those triggers of eryptosis. 
As a matter of fact, the susceptibility of circulating erythrocytes towards triggers of eryptosis increases 
with erythrocyte age39,40. On the other hand, evidence has been reported that newly formed erythrocytes 
are highly susceptible to suicidal death, a phenomenon called neocytolysis41–43. Along those lines, consid-
erable diversity of lysophosphatidic acid (LPA) induced Ca2+ influx and phospatidylserine translocation 
was observed in seemingly morphologically homogeneous erythrocyte populations44. The Ca2+ response 
to LPA was virtually lacking in reticulocytes and still highly variable in old erythrocytes44.
Collectively, the present observations highlight the significance of MSK1/2 for erythrocyte survival. 
Phosphatidylserine-exposing cells are bound to macrophages45, engulfed and degraded46, and thus rap-
idly cleared from circulating blood36,37. Along those lines, msk−/− erythrocytes are cleared more rapidly 
from the circulation. The accelerated erythrocyte death and clearance from circulating blood is out-
weighed by compensatory increase of erythropoiesis in msk−/− mice, which is reflected by increased 
numbers of circulating reticulocytes in those mice.
Mechanistically, exposure of erythrocytes to hypertonic extracellular environment in vitro simu-
lates the osmotic conditions encountered in the kidney medulla. Under pathological conditions such 
as acute renal failure, erythrocytes are trapped in the kidney medulla, thus predisposing erythrocytes 
to eryptosis33. It is, therefore, tempting to speculate that MSK1/2 influences erythrocyte survival and its 
ramifications in systemic conditions such as renal failure. The MSK1/2 upstream molecule p38 MAPK 
orchestrates adaptation to hypertonicity in mammalian cells47,48. In nucleated cells, hypertonic shock 
modulates cAMP response element-binding protein via activation of MSK1-dependent signaling49. In 
erythrocytes, a similar parallel can be drawn as hyperosmotic shock elicits phosphorylation of p38 
MAPK that regulates the eryptosis machinery50. The msk−/− erythrocytes have further an enhanced sen-
sitivity to the eryptotic effect of cellular energy deprivation, another powerful stimulator of eryptosis38. 
Signaling involved in the regulation of eryptosis following cellular energy depletion includes protein 
kinase C, AMP activate kinase and Janus kinase 319.
According to the present data MSK1/2 contributes to both osmo- and energy-sensitive regulation 
of erythrocyte survival. Without stimulation of eryptosis, the percentage of eryptotic cells is similar in 
Figure 6. Effect of energy depletion on forward scatter in erythrocytes from msk−/− and msk+/+ mice. 
(A) Histogram overlay and (B) Means ± SEM (n = 3− 4) of erythrocyte FSC Geomean from glucose-
containing (black line, + Glucose) or glucose-depleted (red line, − Glucose) Ringer. ###(p < 0.001) from 
+ Glucose.
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msk−/− mice and in msk+/+ mice. The susceptibility of the erythrocytes from msk−/− mice to eryptosis 
is, however, apparent following osmotic shock and energy depletion. Eryptosis is enhanced by erythro-
cyte age, a wide variety of anemia-causing xenobiotics and endogenous substances19 and several clinical 
disorders, including iron deficiency, phosphate depletion, hepatic failure, dehydration, fever, Hemolytic 
Uremic Syndrome, end stage renal disease, sepsis, malaria, malignancy and Wilson’s disease19,51. Eryptosis 
may further influence erythrocyte storage for transfusion52. MSK1 deficiency may enhance the suscepti-
bility to the eryptotic effect of those xenobiotics, endogenous substances and clinical disorders. In view 
of the accelerated clearance of erythrocytes and a mild splenomegaly in msk−/− mice, triggers of eryptosis 
are apparently operative in the blood of those mice.
Phosphatidylserine-exposing erythrocytes adhere to the vascular wall53–57 and to other erythrocytes58; 
they further stimulate blood clotting53,59,60. Thus, excessive eryptosis may compromise microcirculation. 
Along those lines, enhanced eryptosis has been suggested to participate in the vascular injury of meta-
bolic syndrome61.
In conclusion, lack of MSK1/2 leads to enhanced susceptibility to suicidal erythrocyte death or eryp-
tosis following osmotic shock and energy depletion leading to accelerated splenic trapping of circulating 
erythrocytes.
Materials and Methods
Human erythrocytes. Highly purified erythrocyte concentrates were provided by the blood bank 
of the University of Tübingen. The erythrocyte concentrates were virtually free of white blood cells and 
contained less than 1% platelets. The Committee approving the experiments, in name, is the ethics com-
mittee of the University of Tübingen, given report number: 184/2003V. Informed consent was obtained 
from all subjects.
Mice. Experiments were performed in 9- to 16-wk-old MSK1/2-deficient mice (msk−/−) as well as 
sex-and age matched wild-type mice (msk+/+) which were fed a control diet (C1314; Altromin, Heidenau, 
Germany) and had access to drinking water ad libitum. The msk−/− mice have been described previ-
ously15,18. The animals were maintained under specific pathogen-free conditions and all experiments 
described in the methods were carried out in accordance with the approved guidelines (American 
Physiological Society as well as the German law and the EU Animals Scientific Procedures Act for the 
welfare of animals) and were approved by local authorities of the state of Baden-Württemberg.
Figure 7. Enhanced clearance and splenic entrapment of eryptotic erythrocytes in msk−/− mice. (A) 
Means ± SEM (n = 3− 4) of the percentages of autologously-injected circulating CFSE-labeled erythrocytes 
plotted against time. (B) Means ± SEM of the spleen/body weight ratio (mg/gram) of msk−/− (n = 21) and 
msk+/+ (n = 33) mice. (C) Confocal images of CFSE-dependent (left panels), annexin V-dependent (middle 
panels) and merged fluorescence (right panels) and (D) Means ± SEM (n = 3− 4) of number of CFSE and 
annexin V positive splenic erythrocytes from msk−/− and msk+/+ mice. *(p < 0.05) from msk+/+.
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Blood count and isolation of murine erythrocytes. For all experiments except for the blood 
count, heparin blood was retrieved from the retrobulbar plexus of mice62. For the blood count, EDTA 
blood was analyzed using an electronic hematology particle counter (type MDM 905 from Medical 
Diagnostics Marx; Butzbach, Germany) equipped with a photometric unit for haemoglobin determina-
tion. To obtain pure erythrocytes, murine erythrocytes were separated utilizing Ficoll (Biochrom AG, 
Germany) and washed twice with Ringer solution containing (in mM): 125 NaCl, 5 KCl, 1 MgSO4, and 
32 HEPES/NaOH (pH 7.4), 5 glucose, and 1 CaCl2.
Reticulocyte count. For determination of the reticulocyte count EDTA-whole blood (5 μ l) was added 
to 1 ml Retic-COUNT (Thiazole orange) reagent from Becton Dickinson. Samples were stained for 30 min 
at room temperature, and flow cytometry was performed according to the manufacturer’s instructions. 
Forward scatter (FSC), side scatter (SSC), and Thiazole orange-fluorescence intensity (in FL-1) of the 
blood cells were determined. The number of Retic-COUNT positive reticulocytes was expressed as the 
percentage of the total gated erythrocyte populations. Gating of erythrocytes was achieved by analysis of 
FSC vs. SSC dot plots using CellQuest software.
Determination of the osmotic resistance. For measurement of osmotic resistance 2 μ l erythrocyte 
pellets were exposed in a 96 well plate for 2 min to phosphate-buffered saline (PBS) solutions (in mM: 
1.05 KH2PO4, 2.97 Na2HPO4, 155.2 NaCl) of decreasing osmolarity as prepared by mixing a PBS solution 
with a defined volume of distilled water. After centrifugation (500 g for 5 min), the Hb concentration of 
the supernatants was determined photometrically (at 405 nm).
Incubations and solutions. For in vitro analysis of eryptosis, erythrocytes were isolated by washing 
two times and subsequent incubation in vitro at a hematocrit of 0.4% in Ringer solution at 37 °C for the 
indicated time periods. Where indicated, glucose was removed or sucrose (550 mM) added to the Ringer 
solution.
Phosphatidylserine exposure and forward scatter. After incubation, erythrocytes were washed 
once in Ringer solution containing 5 mM CaCl2. The cells were then stained with annexin V-FITC (1:250 
dilution; Immunotools, Friesoythe, Germany) at a 1:500 dilution. After 15 min, samples were measured 
by flow cytometric analysis (FACS-Calibur; BD). Cells were analyzed by forward scatter, and annexin 
V-fluorescence intensity was measured with an excitation wavelength of 488 nm and an emission wave-
length of 530 nm on a FACS calibur (BD, Heidelberg, Germany).
Measurement of the in vivo clearance of fluorescence-labeled erythrocytes. The in vivo 
clearance of fluorescence-labeled erythrocytes was determined as described previously63. Briefly, 
erythrocytes (obtained from 200 μ l blood) were fluorescence-labeled by staining the cells with 5 μ M 
carboxyfluorescein-diacetate-succinimidyl-ester (CFSE) (Molecular Probes, Leiden, Netherlands) in PBS 
and incubated for 30 min at 37 °C. After washing twice in PBS containing 10% FCS the pellet was resus-
pended in Ringer solution (37 °C), and 100 μ l of the CFSE-labelled erythrocytes (50% hematocrit) were 
injected into the tail vein of the recipient mouse. As indicated, blood was retrieved from the tail veins 
of the mice, and CFSE-dependent fluorescence intensity of the erythrocytes was measured as described 
above. The percentage of CFSE-positive erythrocytes was calculated in % of the total labelled fraction 
determined 10 min after injection.
Confocal microscopy. For the detection of annexin V-binding and CFSE-dependent fluorescence 
of erythrocytes in the spleen, the spleens of msk−/− and msk+/+ mice were homogenized mechanically 
in 1 ml cold PBS. The suspension was then centrifuged at 500 g for 10 min at 4 °C. The cell pellet was 
resuspended in 200 μ l cold PBS. Five μ l of Annexin V-APC (BD, Heidelberg, Germany) were added, and 
incubation was carried out for 20 min at 37 °C protected from light. Then, the suspension was transferred 
onto a glass slide and mounted with Prolong® Gold antifade reagent (Invitrogen). Images were taken 
on a Zeiss LSM 5 EXCITER Confocal Laser Scanning Microscope (Carl Zeiss MicroImaging GmbH, 
Germany) with a water immersion Plan-Neofluar 63/1.3 NA DIC.
Immunoblotting. To remove the haemoglobin, 200 μ l erythrocyte pellet (1 × 109 cells) were haemo-
lysed in 50 ml of 20 mM HEPES/NaOH (pH 7.4) containing 1 complete protease inhibitor cocktail (Roche). 
Ghost membranes were pelleted (20,000 g for 20 min at 4 °C) and lysed in 200 μ l lysis buffer (125 mM 
NaCl, 25 mM HEPES/NaOH (pH 7.4), 10 mM Na2-EDTA, 10 mM NaF, 10 mM Na-pyrophosphate tetra-
basic decahydrate, 0.1% sodium dodecyl sulfate (SDS), 0.5% deoxycholic acid, 1% Triton X-100, 0.4% 
β -mercaptoethanol and 1 complete protease inhibitor cocktail. Lysed ghost membranes were solubilized 
in Laemmli sample buffer at 95 °C for 5 min and stored at − 20 °C. The murine erythrocytes were washed 
after isolation from full blood by a single purification step with Ficoll and then lysed in the same lysis 
buffer as above.
For each lane, equal amounts of protein were loaded and resolved by 8–10% SDS-PAGE precast gel 
(Invitrogen). For immunoblotting, proteins were electrotransferred onto a PVDF membrane and blocked 
with 5% non-fat milk in TBS-0.1% Tween 20 (TBS-T) at room temperature for 1 h. The membrane was 
www.nature.com/scientificreports/
9Scientific RepoRts | 5:17316 | DOI: 10.1038/srep17316
incubated with rabbit anti-MSK1 (C27B2; #3489) antibody (1:500; 90 kDa) (Cell signaling, USA) or rab-
bit anti-MSK2 (NBP2-30079) antibody (1:1000; 86 kDa, Novus Biological, USA) or 1:1000 anti-GAPDH 
antibody (1:1000; 37 kDa, Cell Signaling) at 4 °C overnight in 5% BSA. After washing with TBS-T the 
blots were incubated with secondary anti-rabbit antibody (1:2000; Cell Signaling) for 1 h at room temper-
ature. After washing, antibody binding was detected with the ECL detection reagent (Life technologies, 
Germany).
Statistics. Data are expressed as arithmetic means ± SEM, and statistical analysis was made using 
ANOVA or t-test, as appropriate. n denotes the number of different erythrocyte specimens studied.
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